Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




NIH’s Observational Medical Outcomes Partnership Seeks Public Feedback on Research Priorities

By LabMedica International staff writers
Posted on 17 Sep 2012
The Foundation for the US National Institutes of Health (Bethesda, MD, USA) managed Observational Medical Outcomes Partnership (OMOP) is seeking public feedback on proposed research priorities and tasks. More...


OMOP was formed in 2008 to conduct methodologic research to inform the suitable use of observational healthcare data for studying the effects of medical products. OMOP has generated empirical evidence about the performance of observational analysis methods to identify real risks of medical products and discriminate from false findings. The basic goal of this research is to develop and evaluate standardized algorithms that can effectively distinguish positive from negative controls, and to understand how an estimated effect from an observational study relates to the true relationship between medical product exposure and adverse events.

As part of its research, OMOP has developed tools and capabilities for transforming, characterizing, and examining disparate data sources across the healthcare delivery spectrum, and has established a shared resource to enable collaborative research. OMOP’s research continues to reiterate the idea that advancing the science of observational research requires an empirical and reproducible approach to methodology and its systematic application.

To continue the effort, the OMOP executive board proposed a series of priorities, infrastructure tasks, and research tasks to guide the development of OMOP’s research agenda for 2013-2016.

The OMOP executive board is seeking comment on the adequacy and completeness of the research priorities and tasks. “Receiving public feedback regarding OMOP’s work is vital to our success,” said OMOP executive board member, Ronald Krall, MD. “We want to make sure we hear every idea about how to use healthcare data to improve the safety and effectiveness of medical products.”

The proposed research priorities and tasks are found on the OMOP website with instructions on how to provide feedback. Comments can be given through September 15, 2012.

Established by the United States Congress to support the mission of the NIH--improving health through scientific discovery in the search for cure--the Foundation for the NIH is a leader in identifying and addressing complex scientific and health issues.

Related Links:
Foundation for the US National Institutes of Health
Observational Medical Outcomes Partnership


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.